Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Clinical trial NCT05809024 · UNKNOWN

Trial details

NCT number: NCT05809024
Sponsor: Yongsheng Wang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer Hormone Receptor Positive，HER2-negative Breast Cancer

Start date: 2023-03-01
Primary completion: 2025-03-25
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.